The biotech and pharma stocks to watch on Tuesday include iSpecimen, which gained more than 37% in overnight trading on Monday despite no specific news; Genelux, with a key clinical catalyst for its lead candidate Olvi-Vec expected in the coming months; Anixa Biosciences, which is scheduled to present at the Nasdaq & LD Micro Inaugural SF Summit; and Biofrontera, which has an important FDA regulatory decision expected later this month, among others. Read on… iSpecimen Inc. (ISPC), an online global marketpl ...